Showing posts with label copycat drugs. Show all posts
Showing posts with label copycat drugs. Show all posts

Monday, May 22, 2017

The World’s Best-Selling Drug Just Lost a Key Patent Battle; Fortune, May 18, 2017

Sy Mukherjee, Fortune; 

The World’s Best-Selling Drug Just Lost a Key Patent Battle


"The rheumatoid arthritis and psoriasis medicine has recently been a target of biopharma companies that are trying to make generic Humira copycats called "biosimilars."...

Once the drug does fall off the patent cliff, however, AbbVie could be in for some rough times. Humira sales make up more than 60% of its revenues."